AstraZeneca (LON:AZN) Insider Nazneen Rahman Sells 297 Shares of Stock

AstraZeneca PLC (LON:AZN) insider Nazneen Rahman sold 297 shares of the company’s stock in a transaction dated Thursday, December 18th. The shares were sold at an average price of £134.96, for a total value of £40,083.12.

AstraZeneca Trading Down 0.5%

Shares of AstraZeneca stock opened at £136.02 on Tuesday. The company’s 50-day moving average price is £132.38 and its 200-day moving average price is £119.43. The company has a current ratio of 0.93, a quick ratio of 0.59 and a debt-to-equity ratio of 73.83. AstraZeneca PLC has a 12-month low of GBX 9,573.51 and a 12-month high of £142.06. The company has a market cap of £210.87 billion, a price-to-earnings ratio of 22.59, a PEG ratio of 0.86 and a beta of 0.17.

Wall Street Analyst Weigh In

Several research analysts have commented on the stock. Berenberg Bank raised their price target on shares of AstraZeneca from £142 to £145 and gave the company a “buy” rating in a report on Tuesday, October 21st. JPMorgan Chase & Co. reiterated an “overweight” rating and issued a £140 price objective on shares of AstraZeneca in a research report on Thursday, December 4th. Jefferies Financial Group reissued a “buy” rating and set a £150 price objective on shares of AstraZeneca in a research note on Monday, November 10th. Finally, Shore Capital restated a “buy” rating and set a £145 target price on shares of AstraZeneca in a research report on Thursday, November 6th. Four equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of £138.

AstraZeneca Company Profile

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology.
Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on Twitter @AstraZeneca.